---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-057901"
form_type: "8-K"
ticker: "NERV"
cik: "0001598646"
company_name: "Minerva Neurosciences, Inc."
filed_at: "2025-03-19T23:59:59+00:00"
generated_at: "2026-05-24T11:47:18.233046+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Minerva Neurosciences regains Nasdaq compliance with net income rule

## Summary
- Nasdaq Panel confirmed compliance with Listing Rule 5550(b)(3) (minimum $500K net income from continuing operations).
- Company subject to a one-year discretionary monitor; any future deficiency triggers automatic delist process.
- Prior deficiencies for Market Value of Listed Securities (<$35M) and Equity Rule are now resolved.
- Panel closed the matter; listing on Nasdaq Capital Market continues effective March 17, 2025.

## SEC filing metadata
- accession: 0001193125-25-057901
- form_type: 8-K
- ticker: NERV
- cik: 0001598646
- company_name: Minerva Neurosciences, Inc.
- filed_at: 2025-03-19T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1598646/000119312525057901/0001193125-25-057901-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1598646/000119312525057901/d841978d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-057901
- JSON: https://secwatch.observer/filing/0001193125-25-057901.json
- Plain text: https://secwatch.observer/filing/0001193125-25-057901.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.